National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Beijing Municipality, 100021, China
NCT Number: NCT06544668
The purpose of this study is to identify the risk factors of bone metastasis in breast cancer patients so as to develop a dynamic prediction model using real world clinical data. The multicenter data will be retrospectively collected, and the clinical characteristics related to bone metastasis will be analyzed.
Trial opening soon.
Get Notified20 year–70 year
Female
Observational
Beijing, Beijing Municipality, 100021, China
Breast cancer is the most common malignant tumor in women worldwide and bones are the most common sites of metastases in breast cancer patients(~70%). Bone metastasis often leads to skeletal-related events (SREs) ,which may not only reduce the quality of life in patients, but also affect the long-term survival. Therefore, early detection and early intervention of bone metastasis are particularly important for breast cancer patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This study is an observational study
This study is an observational study
Time frame: 60 months
The correlation between clinical characteristics and bone metastasis, and the accuracy of prediction model
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Other
A Clinical Study to Establish a Dynamic Prediction Model for Bone Metastases Based on Breast Cancer Real-world Data
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07687225
Bone Metastases, Breast Cancer
View Trial DetailsNCT00566618
Bone Metastases, Breast Cancer
Chicago, Illinois, United States
View Trial DetailsNCT04947280
Bone Metastases, Breast Cancer
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT03661892
Bone Metastases, Breast Cancer
Tucson, Arizona, United States
View Trial Details